Houston, TX 的 消化系統疾病 臨床試驗
8 項針對 消化系統疾病 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Baylor College of Medicine, Houston
- Intergrity Research, Houston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Oncology Consultants P.A., Houston
- Oncology Consultants P.A., Houston
- Texas Oncology - Gulf Coast, Houston
- 還有 7 項
Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
招募中
- Baylor College of Medicine / Texas Children's Hospital, Houston
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
招募中3 期
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 還有 1 項
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
招募中3 期
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
- 89bio Clinical Study Site, Houston
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
招募中
- University of Texas Health Science Center at Houston, Houston
GpCRC Pediatric Gastroparesis Registry 2
招募中觀察性研究
- Baylor College of Medicine/Texas Children's Hospital, Houston
其他城市的 消化系統疾病 試驗
- Chicago, IL8 項研究
- New York City, NY8 項研究
- Washington, DC6 項研究
- San Diego, CA6 項研究
- Durham, NC6 項研究
- Boston, MA6 項研究
- St. Louis, MO5 項研究
- Seattle, WA5 項研究
- Louisville, KY5 項研究
- Rochester, MN5 項研究
- Nashville, TN5 項研究
- Chandler, AZ5 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。